USTR Seeks Public Comments on China’s WTO Compliance Estimated reading time: 2–5 minutes The Office of the United States Trade Representative (USTR) is asking for public comments about how China is following the rules of the World Trade Organization (WTO). USTR will use the comments to prepare a report for Congress. This happens every year. People can also ask to speak at a public hearing. Key Dates The deadline for sending comments, requests to testify, and summaries of testimony is September 24, 2025, at 11:59 p.m. EDT. The public hearing will be on October 7, 2025, at 9:30 a.m. EDT. How to Send Comments USTR wants people to send comments online through www.regulations.gov. Use Docket Number USTR-2025-0015 to find the correct place to submit. If online submission is not possible, contact Alex Martin, Deputy Director for China Affairs, before the deadline at 202.395.9625 or by email. Information to Include Comments or testimony should talk about China’s promises as a WTO member. These areas include: A. Trading rights B. Import rules (such as tariffs, quotas, and licenses) C. Export rules D. Internal trade policies (including subsidies, standards, taxes, and government procurement) E. Intellectual property rights F. Services G. Rule of law (such as transparency and legal reform) H. Other WTO commitments USTR also wants to hear about any unresolved issues. About the Hearing To speak at the hearing, people must send a request and a summary of their talk by the deadline. Each speaker has up to five minutes. No business confidential information should be shared in oral testimony. Small businesses, or groups representing small businesses, should say so in their comments. Written Submission Rules Send comments by September 24, 2025, at 11:59 p.m. EDT. Write in English. Keep submissions to 30 single-spaced, letter-size pages in 12-point font. Include: (1) 2025 China WTO Compliance Report, (2) organization’s name, and (3) type of submission (“written comment,” “request to testify,” or “summary of written testimony”). Do not send attachments or cover letters as separate files. All content should be in one file. After submitting, a tracking number will be given. Keep this number. If Submitting Business Confidential Information Clearly mark each page containing business confidential information as “BUSINESS CONFIDENTIAL.” The file name for confidential submissions must start with “BCI.” Also send a public version labeled “P.” USTR will not share business confidential information with the public. Viewing Comments All non-confidential submissions can be viewed by the public online at www.regulations.gov, using Docket Number USTR-2025-0015. Contact Information Questions or requests for alternative submission methods should be sent to Alex Martin, Deputy Director for China Affairs, at 202.395.9625. General Information More on the USTR can be found at www.ustr.gov. Published by: Edward Marcus, Chair of the Trade Policy Staff Committee, Office of the United States Trade Representative Federal Register, August 18, 2025 Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.

USTR Extends Product Exclusions for Certain Chinese Imports Until August 31, 2025 Estimated reading time: 3–5 minutes On June 5, 2025, the Office of the United States Trade Representative (USTR) published a notice in the Federal Register. The USTR announced an extension of certain product exclusions under the Section 301 investigation. This investigation is about China’s acts, policies, and practices related to technology transfer, intellectual property, and innovation. Background Information In earlier notices, USTR removed some products from extra duties that had been placed on imports from China. These products were excluded as part of the Section 301 investigation. The USTR had asked for public comments about whether to extend these exclusions. On December 29, 2023, USTR requested comment on 352 reinstated product exclusions and 77 COVID-related exclusions. On May 30, 2024, USTR decided to extend 164 of these exclusions. Also, on September 18, 2024, they announced 14 exclusions for certain solar manufacturing equipment. New Extension Decision After reviewing the public comments, advisory committee advice, and input from the interagency Section 301 Committee, the USTR has chosen to extend the 164 previously extended exclusions and the 14 solar equipment exclusions. The new extension lasts for three months. These exclusions now remain in effect through August 31, 2025. Details for Importers The extension affects products described in the exclusions. The description and scope of each exclusion will follow the rules in the ten-digit Harmonized Tariff Schedule of the United States (HTSUS) and the specified product descriptions. For items eligible under these rules, U.S. Customs and Border Protection will give instructions about entering goods under the exclusions. Annex A: Heading 9903.88.69 All exclusions under heading 9903.88.69 and its related notes to the HTSUS are extended. The new exclusion period covers goods entered for consumption or withdrawn from warehouses for consumption between 12:01 a.m. eastern standard time on June 1, 2025, and 11:59 p.m. eastern daylight time on August 31, 2025. The article description for heading 9903.88.69 will now say “August 31, 2025” instead of “May 31, 2025”. Annex B: Heading 9903.88.70 All exclusions under heading 9903.88.70 and the related note to the HTSUS are also extended. This extension applies to goods entered, or withdrawn for consumption, between 12:01 a.m. eastern standard time on June 1, 2025, and 11:59 p.m. eastern daylight time on August 31, 2025. The heading’s date is updated from “June 1, 2025,” to “September 1, 2025”. Future Actions USTR may consider more extensions or changes in the future. For more information, contact Senior Associate General Counsel Philip Butler at 202.395.5725. Source: Federal Register Volume 90, Number 107 (Thursday, June 5, 2025) [FR Doc. 2025-10203] Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.

USTR Requests Comments on Foreign Nations’ Impact on U.S. Drug Prices Estimated reading time: 3–5 minutes USTR Requests Comments on Foreign Nations’ Impact on U.S. Drug Prices On May 30, 2025, the Office of the United States Trade Representative (USTR) sent out a request for comments about foreign countries’ drug pricing rules and their effects on American patients. This action follows President Biden’s Executive Order 14297, “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.” The order says that Americans should not have to pay more for prescription drugs because other countries pay less. It asks that Americans get the best price for prescription drugs, like the lowest price charged to other nations. USTR is asking for information about any foreign act, policy, or practice that makes American patients pay too much for drug research and development. In particular, USTR is interested in any action that forces drug prices down in other countries, making the United States carry more of the costs. How to Comment Comments are due by June 27, 2025. To submit a comment, use the USTR portal at https://comments.ustr.gov/s/. The comments should use docket number USTR-2025-0011. If you cannot use the website, you can contact Deputy Assistant U.S. Trade Representative for Monitoring and Enforcement, Catherine Gibson, at 202.395.5725 or by email. What to Include in Your Comment USTR wants comments that name the foreign country or area, describe the act, policy, or practice, and tell why it may be unfair or discriminatory. Comments should also explain how this affects American patients and raises their share of drug research and development costs. Anyone can send comments, including individuals, companies, and groups. The request repeats that parties are always welcome to send information about trade concerns. Instructions for Submitting Comments To submit online, go to the portal and choose the right docket. You do not need to create an account. Enter your contact details. Organizations must include their legal name and contact information. There are options to mark parts of the comment as Business Confidential Information (BCI) or as Public. Mark any BCI as “BUSINESS CONFIDENTIAL” and highlight the confidential information. You must also send a public version without the confidential details. If you need other ways to protect confidential business information, you can contact Catherine Gibson at 202.395.5725 to discuss options. Submitted documents will be posted for public inspection, except for properly marked confidential information. Contact for Questions To discuss submission problems or for other questions, you may contact Catherine Gibson, Deputy Assistant U.S. Trade Representative for Monitoring and Enforcement, at 202.395.5725. The request for comments was signed by Jennifer Thornton, General Counsel, Office of the United States Trade Representative. Official notice number: 2025-09757. For more details, visit the Federal Register at https://www.gpo.gov. Legal Disclaimer This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.